PCVX Chart
- 52-Week Range: $17.46 - $26.97
- Market Capitalization: $1.55B
- Short Percentage: 0%
- Target Price: $48.50
- Shares Outstanding: 58.31M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
PCVX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire | May 9th
- Vaxcyte to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire | April 5th
- Vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Vaxcyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire | February 28th
- Vaxcyte to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022GlobeNewsWire | February 17th
- Vaxcyte to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire | February 10th
- Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewsWire | January 12th
- Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of DirectorsGlobeNewsWire | October 28th
Company Info
Website: https://vaxcyte.com
Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Sector: Healthcare
Industry: Biotechnology
Full time employees: 89
Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Sector: Healthcare
Industry: Biotechnology
Full time employees: 89
$PCVX bounce it!!
$PCVX HERE WE GO
$PCVX Reinvest your dividends
$PCVX just waiting to short this bad boy.
$PCVX holdddd it tight yall
$PCVX Buy the dip
$PCVX nice!!!
$PCVX good support.....
$PCVX in it to win it
$PCVX Buy the dip